Ashton R, Weinstein M. Acne vulgaris in the pediatric patient. Pediatr Rev. 2019;40(11):577-589.
- Collier CN, Harper JC, Cafardi JA, et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol. 2008;58(1):56-59.
- Eichenfield L, Hebert A, Desai SR, et al. The new face of preadolescent and adolescent acne: beyond the guidelines. J Fam Pract. 2022;71(6 Suppl):S63-S70.
Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168(3):474-485.
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973.e33.
Heng AHS, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep. 2020;10(1):5754.
- Rout A, Das A. Does weight loss lead to improvement of dermatological conditions: what is the evidence? Clin Exp Dermatol. 2022;47(8):1446-1453.
Arafa A, Mostafa A, Khamis Y. The association of acne and menstrual symptoms among young women (18-25 years) in Egypt: a population-based cross-sectional study. Int J Adolesc Med Health. 2020;33(6):463-468.
Fusano M. Veganism in acne, atopic dermatitis, and psoriasis: benefits of a plant-based diet. Clin Dermatol. 2023;41(1):122-126.
Meixiong J, Ricco C, Vasavda C, Ho BK. Diet and acne: a systematic review. JAAD Int. 2022;7:95-112.
Mills OH, Kligman A. Acne mechanica. Arch Dermatol. 1975;111(4):481-483.
Basler RS. Acne mechanica in athletes. Cutis. 1992;50(2):125-128.
Teo WL. The “Maskne” microbiome - pathophysiology and therapeutics. Int J Dermatol. 2021;60(7):799-809.
Eichenfield DZ, Sprague J, Eichenfield LF. Management of acne vulgaris: a review. JAMA. 2021;326(20):2055-2067.
- Eichenfield LF, Krakowski AC, Piggott C, et al. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics. 2013;131(Suppl 3):S163-S186.
Antoniou C, Dessinioti C, Stratigos AJ, Katsambas AD. Clinical and therapeutic approach to childhood acne: an update. Pediatr Dermatol. 2009;26(4):373-380.
- Bernier V, Weill FX, Hirigoyen V, et al. Skin colonization by Malassezia species in neonates: a prospective study and relationship with neonatal cephalic pustulosis. Arch Dermatol. 2002;138(2):215-218.
Ayhan M, Sancak B, Karaduman A, Arikan S, Şahin S. Colonization of neonate skin by Malassezia species: relationship with neonatal cephalic pustulosis. J Am Acad Dermatol. 2007;57(6):1012-1018.
Cantatore-Francis JL, Glick SA. Childhood acne: evaluation and management. Dermatol Ther. 2006;19(4):202-209.
O’Connor NR, McLaughlin MR, Ham P. Newborn skin: part I. Common rashes. Am Fam Physician. 2008;77(1):47-52.
Van Praag MCG, Van Rooij RWG, Folkers E, Spritzer R, Menke HE, Oranje AP. Diagnosis and treatment of pustular disorders in the neonate. Pediatr Dermatol. 1997;14(2):131-143.
- Tan J, Wolfe B, Weiss J, et al. Acne severity grading: determining essential clinical components and features using a Delphi consensus. J Am Acad Dermatol. 2012;67(2):187-193.
Habeshian KA, Cohen BA. Current issues in the treatment of acne vulgaris. Pediatrics. 2020;145(Suppl 2):S225-S230.
- Conforti C, Giuffrida R, Fadda S, et al. Topical dermocosmetics and acne vulgaris. Dermatol Ther (Heidelb). 2021;34(1):e14436.
Draelos ZD. The effect of a daily facial cleanser for normal to oily skin on the skin barrier of subjects with acne. Cutis. 2006;78(1 Suppl):34-40.
- Piquero-Casals J, Morgado-Carrasco D, Rozas-Muñoz E, et al. Sun exposure, a relevant exposome factor in acne patients and how photoprotection can improve outcomes. J Cosmet Dermatol. 2023;22(6):1919-1928.
Cunliffe WJ, Holland KT, Bojar R, Levy SF. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. Clin Ther. 2002;24(7):1117-1133.
Krishnan G. Comparison of two concentrations of tretinoin solution in the topical treatment of acne vulgaris. Practitioner. 1976;216(1291):106-109.
- Tolaymat L, Dearborn H, Zito PM. Adapalene. StatPearls Publishing; 2023. https://www.ncbi.nlm.nih.gov/books/NBK482509/
- Shalita A, Weiss JS, Chalker DK, et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial. J Am Acad Dermatol. 1996;34(3):482-485.
Verschoore M, Langner A, Wolska H, Jablonska S, Czernielewski J, Schaefer H. Efficacy and safety of CD 271 alcoholic gels in the topical treatment of acne vulgaris. Br J Dermatol. 1991;124(4):368-371.
- Cunliffe WJ, Caputo R, Dreno B, et al. Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials. J Am Acad Dermatol. 1997;36(6 Pt 2):S126-S134.
Webster GF, Berson D, Stein LF, Fivenson DP, Tanghetti EA, Ling M. Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial. Cutis. 2001;67(6 Suppl):4-9.
Kakita L. Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris. J Am Acad Dermatol. 2000;43(2 Pt 3):S51-S54.
- Shutter MC, Akhondi H. Tetracycline. StatPearls Publishing; 2023. https://www.ncbi.nlm.nih.gov/books/NBK549905/
Del Rosso JQ. Sarecycline and the narrow-spectrum tetracycline concept: currently available data and potential clinical relevance in dermatology. J Clin Aesthet Dermatol. 202;13(10):45-48.
Garner SE, Eady A, Bennett C, Newton JN, Thomas K, Popescu CM. Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev. 2012(8):CD002086.
- Costa CS, Bagatin E, Martimbianco ALC, et al. Oral isotretinoin for acne. Cochrane Database Syst Rev. 2018(11):CD009435.
Bagatin E, Costa CS. The use of isotretinoin for acne - an update on optimal dosing, surveillance, and adverse effects. Expert Rev Clin Pharmacol. 2020;13(8):885-897.
Blasiak RC, Stamey CR, Burkhart CN, Lugo-Somolinos A, Morrell DS. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris. JAMA Dermatol. 2013;149(12):1392-1398.
Kotori MG. Low-dose Vitamin “A” tablets–treatment of acne vulgaris. Med Arch. 2015;69(1):28-30.
- Mirnezami M, Rahimi H. Is oral omega-3 effective in reducing mucocutaneous side effects of isotretinoin in patients with acne vulgaris? Dermatol Res Pract. 2018;2018:6974045.
Kapała J, Lewandowska J, Placek W, Owczarczyk-Saczonek A. Adverse events in isotretinoin therapy: a single-arm meta-analysis. Int J Environ Res Public Health. 2022;19(11):6463.
Karaosmanoğlu N, Mülkoğlu C. Analysis of musculoskeletal side effects of oral isotretinoin treatment: a cross-sectional study. BMC Musculoskelet Disord. 2020;21(1):631.
Ruiz-Lozano RE, Hernández-Camarena JC, Garza-Garza LA, Bustamante-Arias A, Colorado-Zavala MF, Cardenas-de la Garza JA. Isotretinoin and the eye: a review for the dermatologist. Dermatol Ther (Heidelb). 2020;33(6):e14029.
Prevost N, English JC. Isotretinoin: update on controversial issues. J Pediatr Adolesc Gynecol. 2013;26(5):290-293.
- Xia E, Han J, Faletsky A, et al. Isotretinoin laboratory monitoring in acne treatment: a Delphi consensus study. JAMA Dermatol. 2022;158(8):942-948.
iPLEDGE REMS. Prescriber guide. https://ipledgeprogram.com/ResourceDownloadRaw/GuideBestPractices
Lee G, Wolf JR, Somers KE. Administrative burden of iPLEDGE deters isotretinoin prescriptions: results from a survey of dermatologists. Cutis. 2022;110(1):44-47.
Pierson JC, Ferris LK, Schwarz EB. We pledge to change iPLEDGE. JAMA Dermatol. 2015;151(7):701-702.
Roberts EE, Nowsheen S, Davis DMR, Hand JL, Tollefson MM, Wetter DA. Use of spironolactone to treat acne in adolescent females. Pediatr Dermatol. 2021;38(1):72-76.
Perche P, Singh R, Feldman S. Patient preferences for acne vulgaris treatment and barriers to care: a survey study. J Drugs Dermatol. 2022;21(11):1191-1195.
Harper JC. Acne vulgaris: what’s new in our 40th year. J Am Acad Dermatol. 2020;82(2):526-527.
Maruthappu T, Taylor M. Acne and rosacea in skin of colour. Clin Exp Dermatol. 2022;47(2):259-263.
Singh R, Chatim A, Kankaria A, Feldman S. Review of tretinoin-benzoyl peroxide in the treatment of acne vulgaris. J Drugs Dermatol. 2022;21(10):1098-1103.
- Alexis AF, Woolery-Lloyd H, Williams K, et al. Racial/ethnic variations in acne: implications for treatment and skin care recommendations for acne patients with skin of color. J Drugs Dermatol. 2021;20(7):716-725.
Alexis A, Woolery-Lloyd H, Andriessen A, Kang S, Rodriguez D, Callender V. Racial/ethnic variations in acne: a practical algorithm for treatment and maintenance, including skincare recommendations for skin of color patients with acne. J Drugs Dermatol. 2022;21(11):s13223-s132214.
Boos MD, Hollingshead N, Hodax JK. Management of acne in transgender and gender diverse youth part 1: gender affirming care and risk factors for the development of acne. Pediatr Dermatol. 2022;39(6):866-869.
Hollingshead N, Hodax JK, Boos MD. Management of acne in transgender and gender diverse youth part 2: unique considerations and strategies in medical treatment. Pediatr Dermatol. 2022;39(6):870-875.
Paradise SL, Landis CA, Klein DA. Evidence-based contraception: common questions and answers. Am Fam Physician. 2022;106(3):251-259.
Peitzmeier S, Gardner I, Weinand J, Corbet A, Acevedo K. Health impact of chest binding among transgender adults: a community-engaged, cross-sectional study. Cult Health Sex. 2017;19(1):64-75.
- Motosko CC, Zakhem GA, Pomeranz MK, et al. Effect of testosterone on chests and abdomens of transgender men. J Am Acad Dermatol. 2019;81(2):634-636.
Auffret N, Claudel JP, Leccia MT, Ballanger F, Dreno B. Novel and emerging treatment options for acne vulgaris. Eur J Dermatol. 2022;32(4):451-458.
Soliman YS, Horowitz R, Hashim PW, Nia JK, Farberg AS, Goldenberg G. Update on acne scar treatment. Cutis. 2018;102(1):21-48.
Ren Z, Silverberg JI. Burden, risk factors, and infectious complications of cellulitis and erysipelas in US adults and children in the emergency department setting. J Am Acad Dermatol. 2021;84(5):1496-1503.
- Yueh CM, Chi H, Chiu NC, et al. Etiology, clinical features, management, and outcomes of skin and soft tissue infections in hospitalized children: a 10-year review. J Microbiol Immunol Infect. 2022;55(4):728-739.
- Galli L, Venturini E, Bassi A, et al. Common community-acquired bacterial skin and soft-tissue infections in children: an intersociety consensus on impetigo, abscess, and cellulitis treatment. Clin Ther. 2019;41(3):532-551.e17.
- Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):147-159.
Brockman R, Leitenberger S. Review of scabies infestation and selected common cutaneous infections. Pediatr Rev. 2021;42(1):21-32.
Ondusko DS, Nolt D. Staphylococcus aureus. Pediatr Rev. 2018;39(6):287-298.
Hartman-Adams H, Banvard C, Juckett G. Impetigo: diagnosis and treatment. Am Fam Physician. 2014;90(4):229-235.
Raff AB, Kroshinsky D. Cellulitis: a review. JAMA. 2016;316(3):325-337.
- Trottier ED, Farley St-Amand B, Vincent M, et al. Outpatient management of moderate cellulitis in children using high-dose oral cephalexin. Paediatr Child Health. 2022;27(4):213-219.
- Pallin DJ, Binder WD, Allen MB, et al. Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial. Clin Infect Dis. 2013;56(12):1754-1762.
Peghin M, Graziano E, Rovelli C, Grossi PA. Prevention and treatment of recurrent cellulitis. Curr Opin Infect Dis. 2023;36(2):95-101.
- Winters RD, Mitchell M. Folliculitis. StatPearls Publishing; 2023. https://www.ncbi.nlm.nih.gov/books/NBK547754/
Morgan M. Treatment of MRSA soft tissue infections: an overview. Injury. 2011;42(Suppl 5):S11-S17.
Prindaville B, Belazarian L, Levin NA, Wiss K. Pityrosporum folliculitis: a retrospective review of 110 cases. J Am Acad Dermatol. 2018;78(3):511-514.
Long H, Zhang G, Wang L, Lu Q. Eosinophilic skin diseases: a comprehensive review. Clin Rev Allergy Immunol. 2016;50(2):189-213.
- 123: Folliculitis. Section D: Bacterial. Part XIII: Dermatology. In: Usatine RP, Smith MA, Mayeaux EJ Jr, Chumley HS, eds. The Color Atlas and Synopsis of Family Medicine. 3rd ed. McGraw-Hill Education; 2019:750-755.
Marzano AV, Genovese G. Eosinophilic dermatoses: recognition and management. Am J Clin Dermatol. 2020;21(4):525-539.
Clebak KT, Malone MA. Skin infections. Prim Care. 2018;45(3):433-454.
Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: a review of epidemiology, clinical features, management, and prevention. Int J Dermatol. 2007;46(1):1-11.
Koch L, Cerpes U, Binder B, Cerroni L. Disseminated bullous impetigo in atopic dermatitis (‘eczema staphylococcatum’). J Eur Acad Dermatol Venereol. 2021;35(4):e280-e282.
Bangert S, Levy M, Hebert AA. Bacterial resistance and impetigo treatment trends: a review. Pediatr Dermatol. 2012;29(3):243-248.
- Rakshit T, Shenoy MS. How resistant is Staphylococcus aureus to the topical antibiotic mupirocin? J Glob Antimicrob Resist. 2017;8:102-103.
- Rosen T, Albareda N, Rosenberg N, et al. Efficacy and safety of ozenoxacin cream for treatment of adult and pediatric patients with impetigo: a randomized clinical trial. JAMA Dermatol. 2018;154(7):806-813.
Eudaley S. Ozenoxacin (Xepi) for the treatment of impetigo. Am Fam Physician. 2020;101(12):760-761.
- May PJ, Tong SYC, Steer AC, et al. Treatment, prevention and public health management of impetigo, scabies, crusted scabies and fungal skin infections in endemic populations: a systematic review. Trop Med Int Health. 2019;24(3):280-293.
- American Academy of Pediatrics. Group A streptococcal infections. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2015 Report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015:732-744.
- Weir CB, St.Hilaire NJ. Epidermal inclusion cyst. StatPearls Publishing; 2023. https://www.ncbi.nlm.nih.gov/books/NBK532310/
Wu J, Ge L, Wang X, Jin Y. Role of point-of-care ultrasound (POCUS) in the diagnosis of an abscess in paediatric skin and soft tissue infections: a systematic review and meta-analysis. Med Ultrason. 2022;24(3):339-347.
Fenster DB, Renny MH, Ng C, Roskind CG. Scratching the surface: a review of skin and soft tissue infections in children. Curr Opin Pediatr. 2015;27(3):303-307.
Leinwand M, Downing M, Slater D, Beck M, Burton K, Moyer D. Incision and drainage of subcutaneous abscesses without the use of packing. J Pediatr Surg. 2013;48(9):1962-1965.
- Pastorino A, Tavarez MM. Incision and drainage. StatPearls Publishing; 2024. https://www.ncbi.nlm.nih.gov/books/NBK556072/
- Cassidy-Smith T, Mistry RD, Russo CJ, et al. Topical anesthetic cream is associated with spontaneous cutaneous abscess drainage in children. Am J Emerg Med. 2012;30(1):104-109.
Bhattacharya S. Local anaesthesia - not a minor anaesthesia. Indian J Plast Surg. 2011;44(3):375-376.
Bowman JK. Abscess incision and drainage. Prim Care. 2022;49(1):39-45.
- Kaufman B, Alexis A. Eczema in skin of color: what you need to know. National Eczema Association. https://nationaleczema.org/blog/eczema-in-skin-of-color/
Soundararajan V, Charny JW, Bain MA, Tsoukas MM. The color of skin: orange diseases of the skin, nails, and mucosa. Clin Dermatol. 2019;37(5):520-527.
Davis SA, Narahari S, Feldman SR, Huang W, Pichardo-Geisinger RO, McMichael AJ. Top dermatologic conditions in patients of color: an analysis of nationally representative data. J Drugs Dermatol. 2012;11(4):466-473.
Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. JAMA Dermatol. 2017;153(8):760-764.
Tran AX, Lefante JJ, Murina A. Risk factors for dissecting cellulitis of the scalp: a case-control study. J Am Acad Dermatol. 2022;86(4):941-943.
Sharara SL, Maragakis LL, Cosgrove SE. Decolonization of Staphylococcus aureus. Infect Dis Clin North Am. 2021;35(1):107-133.
Ely JW, Rosenfeld S, Seabury Stone M. Diagnosis and management of tinea infections. Am Fam Physician. 2014;90(10):702-710.
Lipner SR, Scher RK. Onychomycosis: clinical overview and diagnosis. J Am Acad Dermatol. 2019;80(4):835-851.
- Section F: Fungal. Part XIII: Dermatology. In: Usatine RP, Smith MA, Mayeaux EJ Jr, Chumley HS, eds. The Color Atlas and Synopsis of Family Medicine. 3rd ed. McGraw-Hill Education; 2019:850-891.
Gupta AK, Skinner AR, Cooper EA. Interdigital tinea pedis (dermatophytosis simplex and complex) and treatment with ciclopirox 0.77% gel. Int J Dermatol. 2003;42(Suppl 1):23-27.
Ilkit M, Durdu M. Tinea pedis: the etiology and global epidemiology of a common fungal infection. Crit Rev Microbiol. 2015;41(3):374-388.
Szepietowski JC, Reich A, Garlowska E, Kulig M, Baran E. Factors influencing coexistence of toenail onychomycosis with tinea pedis and other dermatomycoses: a survey of 2761 patients. Arch Dermatol. 2006;142(10):1279-1284.
Arenas R, Moreno-Coutiño G, Vera L, Welsh O. Tinea incognito. Clin Dermatol. 2010;28(2):137-139.
- Suh DC, Friedlander SF, Raut M, et al. Tinea capitis in the United States: diagnosis, treatment, and costs. J Am Acad Dermatol. 2006;55(6):1111-1112.
Gupta AK, Friedlander SF, Simkovich AJ. Tinea capitis: an update. Pediatr Dermatol. 2022;39(2):167-172.
Vlahovic TC, Garcia M, Wotring K. Dermoscopy of onychomycosis for the podiatrist. Clin Podiatr Med Surg. 2021;38(4):505-511.
Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol. 2007;57(1):1-27.
Chng WQ, Yew YW. Nail manifestations in atopic dermatitis: a systematic review. Int J Dermatol. 2020;59(6):670-676.
Hudson A, Sturgeon A, Peiris A. Tinea versicolor. JAMA. 2018;320(13):1396.
Kallini JR, Riaz F, Khachemoune A. Tinea versicolor in dark-skinned individuals. Int J Dermatol. 2014;53(2):137-141.
Leung AKC, Barankin B, Lam JM, Leong KF, Hon KL. Tinea versicolor: an updated review. Drugs Context. 2022;11:2022-9-2.
Nenoff P, Mügge C, Herrmann J, Keller U. Tinea faciei incognito due to Trichophyton rubrum as a result of autoinoculation from onychomycosis. Mycoses. 2007;50(Suppl 2):20-25.
Szepietowski JC, Matusiak L. Trichophyton rubrum autoinoculation from infected nails is not such a rare phenomenon. Mycoses. 2008;51(4):345-346.
Romano C, Massai L, Strangi R, Feci L, Miracco C, Fimiani M. Tinea corporis purpurica and onychomycosis caused by Trichophyton violaceum. Mycoses. 2011;54(2):175-178.
Hainer BL. Dermatophyte infections. Am Fam Physician. 2003;67(1):101-108.
- Chen X, Jiang X, Yang M, et al. Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev. 2016(5):CD004685.
Zhao D, Chen B, Wang YT, Jiao CH. Topical clotrimazole cream for the treatment of tinea cruris: a retrospective study. Medicine (Baltimore). 2020;99(47):e23189.
Thomas B, Falk J, Allan GM. Topical management of tinea pedis. Can Fam Physician. 2021;67(1):30.
Evans EG, Dodman B, Williamson DM, Brown GJ, Bowen RG. Comparison of terbinafine and clotrimazole in treating tinea pedis. BMJ. 1993;307(6905):645-647.
Kelly BP. Superficial fungal infections. Pediatr Rev. 2012;33(4):e22-e37.
Lyu X, Zhao C, Yan ZM, Hua H. Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis. Drug Des Devel Ther. 2016;10:1161-1171.
Lipner SR, Scher RK. Onychomycosis: treatment and prevention of recurrence. J Am Acad Dermatol. 2019;80(4):853-867.
- Emerson AN, Brodell RT. 51 - Therapeutic shampoos. In: Wolverton S, Wu JJ, eds. Comprehensive Dermatologic Drug Therapy. 4th ed. Elsevier; 2019:576-584.
Wang Y, Lipner SR. Retrospective analysis of abnormal laboratory test results in pediatric patients prescribed terbinafine for superficial fungal infections. J Am Acad Dermatol. 2021;85(4):1042-1044.
Stolmeier DA, Stratman HB, McIntee TJ, Stratman EJ. Utility of laboratory test result monitoring in patients taking oral terbinafine or griseofulvin for dermatophyte infections. JAMA Dermatol. 2018;154(12):1409-1416.
Ricardo JW, Lipner SR. Safety of current therapies for onychomycosis. Expert Opin Drug Saf. 2020;19(11):1395-1408.
Adams BB. Tinea corporis gladiatorum. J Am Acad Dermatol. 2002;47(2):286-290.
Pleacher MD, Dexter WW. Cutaneous fungal and viral infections in athletes. Clin Sports Med. 2007;26(3):397-411.
Awad A, Ismael AF, Sallam M, Abdelgaber S. Intralesional purified protein derivative versus zinc sulfate 2% in the treatment of pediatric warts: clinical and dermoscopic evaluation. J Cosmet Dermatol. 2022;21(10):4637-4645.
Silverberg NB. Pediatric warts: update on interventions. Cutis. 2019;103(1):26-E4.
National Cancer Institute. HPV and cancer. https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer
- Herzum A, Ciccarese G, Occella C, et al. Treatment of pediatric anogenital warts in the era of HPV-vaccine: a literature review. J Clin Med. 2023;12(13):4230.
Hekmatjah J, Farshchian M, Grant-Kels JM, Mehregan D. The status of treatment for plantar warts in 2021: no definitive advancements in decades for a common dermatology disease. Clin Dermatol. 2021;39(4):688-694.
Al Rudaisat M, Cheng H. Dermoscopy features of cutaneous warts. Int J Gen Med. 2021;14:9903-9912.
Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2012(9):CD001781.
Focht DR, Spicer C, Fairchok MP. The efficacy of duct tape vs cryotherapy in the treatment of verruca vulgaris (the common wart). Arch Pediatr Adolesc Med. 2002;156(10):971-974.
Vlahovic TC, Khan MT. The human papillomavirus and its role in plantar warts: a comprehensive review of diagnosis and management. Clin Podiatr Med Surg. 2016;33(3):337-353.
- Rogers CJ, Gibney MD, Siegfried EC, Harrison BR, Glaser DA. Cimetidine therapy for recalcitrant warts in adults: is it any better than placebo? J Am Acad Dermatol. 1999;41(1):123-127.
- Aldahan AS, Mlacker S, Shah VV, et al. Efficacy of intralesional immunotherapy for the treatment of warts: a review of the literature. Dermatol Ther (Heidelb). 2016;29(3):197-207.
Loo SK, Tang WY. Warts (non-genital). BMJ Clin Evid. 2014;2014:1710.
Gay J, Johnson N, Kavuru V, Phillips M. Utility of the human papillomavirus vaccination in management of HPV-associated cutaneous lesions. Skin Therapy Lett. 2021;26(2):6-8.
- Engelman D, Yoshizumi J, Hay RJ, et al. The 2020 International Alliance for the Control of Scabies consensus criteria for the diagnosis of scabies. Br J Dermatol. 2020;183(5):808-820.
Hengge UR, Currie BJ, Jäger G, Lupi O, Schwartz RA. Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis. 2006;6(12):769-779.
Chandler DJ, Fuller LC. A review of scabies: an infestation more than skin deep. Dermatology. 2019;235(2):79-90.
Gunning K, Kiraly B, Pippitt K. Lice and scabies: treatment update. Am Fam Physician. 2019;99(10):635-642.
Pietkiewicz P, Navarrete-Dechent C. Scabies mite is bright green under UV dermatoscopy. Dermatol Pract Concept. 2023;13(2):e2023135.
Yürekli A. A new sign with UV dermoscope in the diagnosis of scabies: ball sign. Skin Res Technol. 2023;29(5):e13336.
Dhana A, Yen H, Okhovat JP, Cho E, Keum N, Khumalo NP. Ivermectin versus permethrin in the treatment of scabies: a systematic review and meta-analysis of randomized controlled trials. J Am Acad Dermatol. 2018;78(1):194-198.
Ogbuefi N, Kenner-Bell B. Common pediatric infestations: update on diagnosis and treatment of scabies, head lice, and bed bugs. Curr Opin Pediatr. 2021;33(4):410-415.
- Levy M, Martin L, Bursztejn AC, et al. Ivermectin safety in infants and children under 15 kg treated for scabies: a multicentric observational study. Br J Dermatol. 2020;182(4):1003-1006.
Drucker AM, Wang AR, Li WQ, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Invest Dermatol. 2017;137(1):26-30.
Waldman AR, Ahluwalia J, Udkoff J, Borok JF, Eichenfield LF. Atopic dermatitis. Pediatr Rev. 2018;39(4):180-193.
Kantor R, Silverberg JI. Environmental risk factors and their role in the management of atopic dermatitis. Expert Rev Clin Immunol. 2017;13(1):15-26.
- Kleinman E, Laborada J, Metterle L, Eichenfield LF. What’s new in topicals for atopic dermatitis? Am J Clin Dermatol. 2022;23(5):595-603.
Akiyama M. FLG mutations in ichthyosis vulgaris and atopic eczema: spectrum of mutations and population genetics. Br J Dermatol. 2010;162(3):472-477.
Frazier W, Bhardwaj N. Atopic dermatitis: diagnosis and treatment. Am Fam Physician. 2020;101(10):590-598.
Napolitano M, Fabbrocini G, Martora F, Genco L, Noto M, Patruno C. Children atopic dermatitis: diagnosis, mimics, overlaps, and therapeutic implication. Dermatol Ther (Heidelb). 2022;35(12):e15901.
Eichenfield LF, Stein Gold LF. Practical strategies for the diagnosis and assessment of atopic dermatitis. Semin Cutan Med Surg. 2017;36(2 Suppl 2):S36-S38.
Weingarten M, Silverberg N. Follicular eczema and accentuation: a survey of published data. J Am Acad Dermatol. 2022;87(4):860-862.
- Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327-349.
- Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657-682. Erratum in J Eur Acad Dermatol Venereol. 2019;33(7):1436.
- Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116-132.
Lee NP, Arriola ER. Topical corticosteroids: back to basics. West J Med. 1999;171(5-6):351-353.
Wolkerstorfer A, Strobos MA, Glazenburg EJ, Mulder PGH, Oranje AP. Fluticasone propionate 0.05% cream once daily versus clobetasone butyrate 0.05% cream twice daily in children with atopic dermatitis. J Am Acad Dermatol. 1998;39(2 Pt 1):226-231.
Hwang J, Lio PA. Topical corticosteroid withdrawal (‘steroid addiction’): an update of a systematic review. J Dermatolog Treat. 2022;33(3):1293-1298.
Stacey SK, McEleney M. Topical corticosteroids: choice and application. Am Fam Physician. 2021;103(6):337-343.
Long CC, Finlay AY. The finger-tip unit—a new practical measure. Clin Exp Dermatol. 1991;16(6):444-447.
- Asif AH, Kaliyadan F, Gite VV, et al. Standardization of topical preparations for finger-tip unit-awareness and attitudes among pharmacists and dermatologists and suggestions to improve standardization of topical drug dosing-a two-phase cross-sectional survey. J Cosmet Dermatol. 2022;21(8):3555-3560.
- Nelson AA, Miller AD, Fleischer AB, Balkrishnan R, Feldman SR. How much of a topical agent should be prescribed for children of different sizes? J Dermatolog Treat. 2006;17(4):224-228.
- 112: Topical and intralesional steroids. Section A: Foundations of Dermatology. Part XIII: Dermatology. In: Usatine RP, Smith MA, Mayeaux EJ Jr, Chumley HS, eds. The Color Atlas and Synopsis of Family Medicine. 3rd ed. McGraw-Hill Education; 2019: 682-683.
- Cadmus SD, Sebastian KR, Warren D, et al. Efficacy and patient opinion of wet-wrap dressings using 0.1% triamcinolone acetonide ointment vs cream in the treatment of pediatric atopic dermatitis: a randomized split-body control study. Pediatr Dermatol. 2019;36(4):437-441.
Pei AYS, Chan HHL, Ho KM. The effectiveness of wet wrap dressings using 0.1% mometasone furoate and 0.005% fluticasone proprionate ointments in the treatment of moderate to severe atopic dermatitis in children. Pediatr Dermatol. 2001;18(4):343-348.
- Paller AS, Simpson EL, Siegfried EC, et al. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2022;400(10356):908-919.
- Paller AS, Siegfried EC, Thaçi D, et al. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial. J Am Acad Dermatol. 2020;83(5):1282-1293.
- Simpson EL, Bieber T, Guttman-Yassky E, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016;375(24):2335-2348.
- Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018;32(6):850-878.
Traidl S, Roesner L, Zeitvogel J, Werfel T. Eczema herpeticum in atopic dermatitis. Allergy. 2021;76(10):3017-3027.
- Simpson EL, Chalmers JR, Hanifin JM, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;134(4):818-823.
Leung DYM. Prophylactic emollient use beginning at birth prevents atopic dermatitis. J Pediatr. 2015;166(3):777-778.
Leitch CS, Chu R, Ray R, Holme SA. Preventing atopic eczema from birth using emollients. J Allergy Clin Immunol. 2015;135(6):1663-1664.
- Sidbury R, Tom WL, Bergman JN, et al. Guidelines of care for the management of atopic dermatitis: section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014;71(6):1218-1233.
Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 2009;123(5):e808-e814.
Monir RL, Schoch JJ. Clinical relevance of the microbiome in pediatric skin disease: a review. Dermatol Clin. 2022;40(2):117-126.
Cartledge N, Chan S. Atopic dermatitis and food allergy: a paediatric approach. Curr Pediatr Rev. 2018;14(3):171-179.
- Boyce JA, Assa’ad A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126(6 Suppl):1105-1118.
Falusi OO. Seborrhea. Pediatr Rev. 2019;40(2):93-95.
Saunte DML, Gaitanis G, Hay RJ. Malassezia-associated skin diseases, the use of diagnostics and treatment. Front Cell Infect Microbiol. 2020;10:112.
- Barba A, Piubello W, Vantini I, et al. Skin lesions in chronic alcoholic pancreatitis. Dermatologica. 1982;164(5):322-326.
Dessinioti C, Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies. Clin Dermatol. 2013;31(4):343-351.
- Li J, Feng Y, Liu C, et al. Presence of Malassezia hyphae is correlated with pathogenesis of seborrheic dermatitis. Microbiol Spectr. 2022;10(1):e0116921.
Victoire A, Magin P, Coughlan J, van Driel ML. Interventions for infantile seborrhoeic dermatitis (including cradle cap). Cochrane Database Syst Rev. 2019(3):CD011380.
Siegfried E, Glenn E. Use of olive oil for the treatment of seborrheic dermatitis in children. Arch Pediatr Adolesc Med. 2012;166(10):967.
Faergemann J. Management of seborrheic dermatitis and pityriasis versicolor. Am J Clin Dermatol. 2000;1(2):75-80.
Pazyar N, Yaghoobi R, Bagherani N, Kazerouni A. A review of applications of tea tree oil in dermatology. Int J Dermatol. 2013;52(7):784-790.
Gupta AK, Ryder JE, Nicol K, Cooper EA. Superficial fungal infections: an update on pityriasis versicolor, seborrheic dermatitis, tinea capitis, and onychomycosis. Clin Dermatol. 2003;21(5):417-425.
Rucker Wright D, Gathers R, Kapke A, Johnson D, Joseph CLM. Hair care practices and their association with scalp and hair disorders in African American girls. J Am Acad Dermatol. 2011;64(2):253-262.
Heath CR, Usatine RP. Seborrheic dermatitis. J Fam Pract. 2021;70(9):E3-E4.
Friedmann DP, Mishra V, Batty T. Progressive facial papules in an African-American patient: an atypical presentation of seborrheic dermatitis. J Clin Aesthet Dermatol. 2018;11(7):44-45.
Elgash M, Dlova N, Ogunleye T, Taylor SC. Seborrheic dermatitis in skin of color: clinical considerations. J Drugs Dermatol. 2019;18(1):24-27.
